Provides RSV immunoprophylaxis( palivizumab) to children under 2 years of age considered high risk for severe RSV disease residing in southern ΒιΆΉΣ³».Submission of the Risk Assessment form by a health care professional is required to determine a child's eligibility for palivizumab. Risk Assessment forms available on the website.
Submission of the Risk Assessment form by a health care professional is required to determine a child's eligibility for palivizumab. Risk Assessment forms available on the website.
Children under the age of 2 with underlying medical conditions considered high risk for severe RSV disease.
Healthcare providers should consult the for service referral information.
Find Healthcare